Hepatocellular adenoma other diagnostic studies

Revision as of 16:23, 15 January 2019 by Zahir Ali Shaikh (talk | contribs)
Jump to navigation Jump to search

Hepatocellular adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatocellular adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular adenoma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular adenoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular adenoma other diagnostic studies

CDC on Hepatocellular adenoma other diagnostic studies

Hepatocellular adenoma other diagnostic studies in the news

Blogs on Hepatocellular adenoma other diagnostic studies

Directions to Hospitals Treating Hepatocellular adenoma

Risk calculators and risk factors for Hepatocellular adenoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]

Overview

The gold standard method for diagnosis of hepatocellular adenoma is excision biopsy of liver lesions either by surgery or laparoscopically. Percutaneous biopsy is not recommended due to the risk of bleeding and tumor dissemination. Other tests that can be used to differentiate between benign and carcinomatous lesions include; QBend10 and erbB2 immunostaining, comparative genomic insitu hybridization and fluorescence insitu hybridization.

Hepatocellular adenoma other diagnostic studies

References

  1. N. Katkhouda, M. Hurwitz, J. Gugenheim, E. Mavor, R. J. Mason, D. J. Waldrep, R. T. Rivera, M. Chandra, G. M. Campos, S. Offerman, A. Trussler, P. Fabiani & J. Mouiel (1999). "Laparoscopic management of benign solid and cystic lesions of the liver". Annals of surgery. 229 (4): 460–466. PMID 10203077. Unknown parameter |month= ignored (help)
  2. F. R. Scott, A. el-Refaie, L. More, P. J. Scheuer & A. P. Dhillon (1996). "Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma". Histopathology. 28 (5): 472–474. PMID 8735726. Unknown parameter |month= ignored (help)
  3. E. M. Brunt & P. E. Swanson (1992). "Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver". American journal of clinical pathology. 97 (5 Suppl 1): S53–S61. PMID 1374219. Unknown parameter |month= ignored (help)
  4. L. Wilkens, M. Bredt, P. Flemming, T. Becker, J. Klempnauer & H. H. Kreipe (2001). "Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization". The Journal of pathology. 193 (4): 476–482. doi:10.1002/path.825. PMID 11276006. Unknown parameter |month= ignored (help)
  5. L. Wilkens, M. Bredt, P. Flemming, Y. Schwarze, T. Becker, M. Mengel, R. von Wasielewski, J. Klempnauer & H. Kreipe (2001). "Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma". The Journal of molecular diagnostics : JMD. 3 (2): 68–73. doi:10.1016/S1525-1578(10)60654-X. PMID 11333302. Unknown parameter |month= ignored (help)
  6. Ludger Barthelmes & Iain S. Tait (2005). "Liver cell adenoma and liver cell adenomatosis". HPB : the official journal of the International Hepato Pancreato Biliary Association. 7 (3): 186–196. doi:10.1080/13651820510028954. PMID 18333188.


Template:WikiDoc Sources